Conatus Pharmaceuticals Inc. (CNAT) surged 13.08% or 0.65 to $5.62. It is near to 1.01 million shares traded, which is 322.25% compare to the average total volume 312821. The market cap of CNAT is $168.63 million. The year to date change is 4.63%. The 52 week price range is from $3.88 to $9.4. Price of CNAT have changed 7.81% during last week. It have changed -0.40% over last month, -1.78% over last 3 months, -19.71% over last 6 months and 8.75% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CNAT is 4.42. It is -21.35% below current price. The 200-day Moving Averages for CNAT is 5.41. It is -3.74% below current price. The 52-week High is 9.4. It is 67.26% from the current price. The 52-week Low is 3.88. It is -30.96% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of CNAT is 3.62 on 2017-12-29. Short % to float is 4.05%. There are some statistics of CNAT. It is has market cap $168.63 million. The share outstanding is 30.01 million. The average volume is 312821. The percent of top 15 Institution holding is 36.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CNAT is -74.50%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CNAT is -36.15%.